AzurRx BioPharma Announces Completion of Enrollment in First Cohort of Phase 2b OPTION 2 Extension Study of MS1819 AZRX broke the support from 1.72 to 1.46 (61.8% fibo). If the decline continues, then buy at 1.20.
Trigger: Waiting for a momentum candle close below the gray area to buy. Good luck!